The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2137-2140

  Araujo, Fausto G ^a   Khan, Anis A ^a   Slifer, Teri L ^a   Bryskier, Andre ^b   Remington, Jack S ^a,c  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b SANOFI   (France)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HMR 3004; MACROLIDE; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0030862066     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2137     Document Type: Article

References (28)

1. Agouridas, C., Y. Beneditti, A. Bonnefoy, P. Collette, A. Denis, P. Mauvais, G. Labbe, and J. F. Chantot. 1996. Ketolides: a new class of macrolide antibacterials. Structural characteristics and biological properties of RU004, p. 97. In Abstracts of the 3rd International Conference on the Macrolides, Azalides and Streptogramins. 1995.
2. Agouridas, C., P. Collette, P. Mauvais, and J. F. Chantot. RU 004: preliminary studies on the mechanism of action, abstr. F170, p. 142. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Araujo, F. G., D. R. Guptill, and J. S. Remington. 1988. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob. Agents Chemother. 32:755-757.
4. Araujo, F. G., J. Huskinson, and J. S. Remington. 1991. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35:293-299.
5. Araujo, F. G., A. A. Khan, and J. S. Remington. 1996. Rifapentine is active in vitro and in vivo against Toxoplasma gondii. Antimicrob. Agents Chemother. 40:1335-1337.
6. Araujo, F. G., P. Prokocimer, T. Lin, and J. S. Remington. 1992. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrob. Agents Chemother. 11:2454-2457.
7. Araujo, F. G., P. Prokocimer, and J. S. Remington. 1992. Clarithromycinminocycline is synergistic in a murine model of toxoplasmosis. J. Infect. Dis. 165:788.
8. Araujo, F. G., and J. S. Remington. 1992. Recent advances in the search tor new drugs for treatment of toxoplasmosis. Int. J. Antimicrob. Agents 1:153-164.
9. Araujo, F. G., and J. S. Remington. 1991. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis. Antimicrob. Agents Chemother. 35:1672-1673.
10. Araujo F. G., and J. S. Remington. 1993. Toxoplasma gondii, p. 177-181. In H. C. Neu, L. S. Young, and S. H. Zinner (coordinating ed.), The new macrolides, azalides, and streptogramins. Pharmacology and clinical applications Marcel Dekker, Inc., Basel, Switzerland.
11. Araujo, F. G., R. M. Shepard, and J. S. Remington. 1991. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii. Eur. J. Clin. Microbiol. Infect. Dis. 10:519-524.
12. Araujo F. G., and T. Slifer. 1995. Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii. Antimicrob. Agents Chemother. 39:2996-2701.
13. Araujo, F. G., T. Slifer, and J. S. Remington. 1994. Rifabutin is active in models of murine toxoplamosis. Antimicrob. Agents Chemother. 38:570-575.
14. Beckers, J. M., D. S. Roos, R. G. K. Donald, B. J. Luft, J. C. Schwab, Y. Cao, and K. A. Joyner. 1995. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. J. Clin. Invest. 95:367-376.
15. Biedenbach, D. J., and R. N. Jones. 1996. In vitro evaluation of new ketolides RU 64004 and RU 66647, against macrolide-resistant gram-positive pathogens, abstr. F221, p. 138. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Chamberland, S., H. A. Kirst, and W. L. Current. 1991. Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay. Antimicrob. Agents Chemother. 35:903-909.
17. Chang, H. R., and J. C. Pechere. 1988. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection. J. Antimicrob. Chemother. 22:87-92.
18. Chang, H. R., and J. C. Pechere. 1987. Effect of roxithromycin on acute toxoplasmosis in mice. Antimicrob. Agents Chemother. 31:1147-1149.
19. Chang, H. R., and J. C. Pechere. 1988. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62993], and A-56268) on Toxoplasma gondii. Antimicrob. Agents Chemother. 32:524-529.
20. Hofflin, J. M., and J. S. Remington. 1987. In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii. Antimicrob. Agents Chemother. 31:346-348.
21. Inderlied, C. B., L. E. Bermudez, L. B. Barbara-Burnham, M. Wu, and L. S. Young. 1996. In vitro and macrophage activity of ketolide derivatives against the Mycobacterium avium complex, abstr. F223, p. 138. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Jamjian, C., D. J. Biedenbach, and R. N. Jones. 1997. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob. Agents Chemother. 41:454-459.
23. Laughon, B. E., H. S. Allaudeeen, J. M. Becker, W. L. Current, J. Feinberg, J. K. Frenkel, R. Hafner, W. T. Hughes, C. Laughlin, J. Mayers, L. K. Schrager, and L. S. Young. 1991. Summary of the Workshop on Future Directions in Discovery and Development of Therapeutic Agents for Opportunistic Infections Associated with AIDS. J. Infect. Dis. 164:244-251.
24. Luft, B. J., R. Hafner, A. Korzum, C. Leport, D. Antoniskis, E. Bosler, and D. Burland. 1993. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 329:995-1000.
25. Mosman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
26. Remington, J. S., R. McLeod, and G. Desmonts. 1995. Toxoplasmosis, p. 140-266. In J. O. Klein and J. S. Remington (coordinating ed.), Infectious diseases of the fetus and newborn infant, 4th ed. The W. B. Saunders Co., Philadelphia, Pa.
27. Wong, S. Y., D. M. Israelski, and J. S. Remington. 1995. AIDS associated toxoplasmosis, p. 460-493. In M. A. Sande and P. A. Volberding (coordinating ed.), The medical management of AIDS. The W. B. Saunders Co., Philadelphia, Pa.
28. Wong, S. Y., and J. S. Remington. 1994. Toxoplasmosis in the setting of AIDS, p. 223-257. In S. Broder, T. C. Merigan, and D. Bolognesi (coordinating ed.), Textbook of AIDS medicine. The Williams & Wilkins Co., Baltimore, Md.